All Access

Pro Rata Premium

Axios Pro Rata Premium

Standard

Axios Pro Rata: Non-Premium Subscribers

Other

"In the long run, (FDA) uncertainty is also creating challenges for new company formation, and if that continues to play out, that is not good for the industry."

Quote of the week

<h2 class="text-h6 !font-sans !font-normal !leading-[1.2em]">&quot;In the long run, (FDA) uncertainty is also creating challenges for new company formation, and if that continues to play out, that is not good for the industry.&quot;</h2><blockquote>— Josh Haimson, CEO of Inductive Bio</blockquote>

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

transportation

business

c-suite

retail-news

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

salt-lake-city

denver

fort-lauderdale

boulder

kansas-city

austin

chicago

dallas

detroit

washington-dc

atlanta

indianapolis

nashville

nw-arkansas

columbus

hollywood

richmond

san-francisco

boston

des-moines

houston

phoenix

miami

philadelphia

seattle

new-orleans

colorado-springs

huntsville

raleigh

san-antonio

twin-cities

pittsburgh

arapahoe

douglas

san-diego

tampa-bay

portland

cleveland

axios-local

axios-pro

axios-live

the-axios-show

Quote of the week

"In the long run, (FDA) uncertainty is also creating challenges for new company formation, and if that continues to play out, that is not good for the industry."

What to read next